Dr. Jonathan Hoggatt is Assistant Professor of Medicine at Harvard Medical School and holds appointments in both the Center for Cancer Research and Center for Transplantation Sciences of Massachusetts General Hospital. Dr. Hoggatt is also a principal faculty member of the Harvard Stem Cell Institute and an affiliate faculty member of the Stem Cell and Regenerative Biology Department at Harvard University. Dr Hoggatt trained with Dr. Louis Pelus at Indiana University School of Medicine and did his post-doctoral training with Dr. David Scadden at Harvard University. Jon is an expert in stem cells and hematopoiesis and his research endeavors focus on translational science in hematopoietic stem cell transplantation. These studies have led to several clinical trials, licensed patents, and high-profile papers in Nature, Nature Medicine, Cell, Blood, Leukemia and others. He holds several patents in novel stem cell therapies and is a co-founder of Magenta Therapeutics.